Brusegard David 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Jun 21, 2012
Insider Transaction Report
Form 4
Brusegard David
Chief Operating Officer
Transactions
- Award
Common Stock Purchase Option (right to buy)
2012-06-20+546,448→ 546,448 totalExercise: $0.00From: 2012-06-20Exp: 2017-06-20→ Common Stock (546,448 underlying)
Footnotes (1)
- [F1]On June 6, 2012, the Board of Directors of the issuer granted the reporting person options to purchase 546,448 shares of the issuer's common stock in lieu of cash payment of deferred compensation, which grant was effective upon the reporting person's execution of a Settlement and Release Agreement with the issuer on June 20, 2012. The grant was made pursuant to the terms of the issuer's 2006 stock plan.